Position in DNA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,430,149
-$1,389,650 QoQ
Shares Held
144,314
-68.6% QoQ
Ownership
0.214%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 183 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 79%
Shared 0%
None 21%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,847,277 across 523 Biotechnology names. DNA ranks #231 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in DNA
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,430,149 | 144,314 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,819,799 | 460,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,369,503 | 766,487 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $4,676,123 | 320,722 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $5,732,243 | 509,533 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $3,623,595 | 635,719 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $5,550,968 | 565,272 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $2,215,151 | 271,798 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 DNABW | — | 1,022 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $2,003,664 | 5,999,010 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 DNABW | — | 719,048 | Shares | Defined | 2024-10-17 | |
| 2024-03-31 | $56,922,659 | 49,071,261 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 DNABW | — | 719,068 | Shares | Defined | 2024-08-16 | |
| 2023-12-31 | $82,747,158 | 48,962,819 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 DNABW | — | 718,868 | Shares | Defined | 2023-11-15 | |
| 2023-09-30 | $90,079,026 | 49,767,420 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 DNABW | — | 718,868 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $89,394,230 | 48,061,418 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 DNABW | — | 718,868 | Shares | Defined | 2023-05-15 | |
| 2023-03-31 | $78,523,752 | 59,040,419 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 DNABW | — | 718,868 | Shares | Defined | 2023-02-14 | |
| 2022-12-31 | $86,332,378 | 51,084,250 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 DNABW | — | 719,268 | Shares | Defined | 2022-11-14 | |
| 2022-09-30 | $169,241,292 | 54,244,005 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 DNABW | — | 719,268 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $93,327,006 | 39,213,029 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 DNABW | — | 719,268 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $100,667,247 | 24,979,467 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 DNABW | — | 719,268 | Shares | Defined | 2022-02-14 | |
| 2021-12-31 | $120,785,647 | 14,534,976 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 DNABW | — | 718,267 | Shares | Defined | 2021-11-15 | |
| 2021-09-30 | $130,670,561 | 11,274,423 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||